A detailed history of Regal Investment Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Regal Investment Advisors LLC holds 109,031 shares of ABBV stock, worth $21.9 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares
109,031
Previous 106,023 2.84%
Holding current value
$21.9 Million
Previous $19.3 Million 3.14%
% of portfolio
1.25%
Previous 1.35%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $465,608 - $543,726
3,008 Added 2.84%
109,031 $18.7 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $911,133 - $1.04 Million
-5,701 Reduced 5.1%
106,023 $19.3 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $188,787 - $212,618
-1,372 Reduced 1.21%
111,724 $17.3 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $593,807 - $687,419
4,445 Added 4.09%
113,096 $16.9 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $239,445 - $297,974
-1,807 Reduced 1.64%
108,651 $14.6 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $1.07 Million - $1.23 Million
7,382 Added 7.16%
110,458 $17.6 Million
Q4 2022

Mar 01, 2023

BUY
$138.31 - $165.87 $476,754 - $571,753
3,447 Added 3.46%
103,076 $16.7 Million
Q3 2022

Nov 15, 2022

BUY
$134.21 - $153.93 $691,852 - $793,509
5,155 Added 5.46%
99,629 $13.4 Million
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $171,199 - $217,650
1,244 Added 1.33%
94,474 $14.5 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $797,951 - $990,032
-6,046 Reduced 6.09%
93,230 $15.1 Million
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $293,606 - $371,496
-2,733 Reduced 2.68%
99,276 $13.4 Million
Q3 2021

Nov 05, 2021

BUY
$106.4 - $120.78 $223,652 - $253,879
2,102 Added 2.1%
102,009 $11 Million
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $10.5 Million - $11.7 Million
99,907 New
99,907 $11.3 Million
Q1 2021

May 12, 2021

SELL
$102.3 - $112.62 $11.6 Million - $12.7 Million
-112,968 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $9.09 Million - $12.3 Million
112,968 New
112,968 $12.1 Million
Q1 2020

May 12, 2020

SELL
$64.5 - $97.79 $6.27 Million - $9.5 Million
-97,162 Closed
0 $0
Q4 2019

Jan 29, 2020

SELL
$72.13 - $90.25 $174,266 - $218,044
-2,416 Reduced 2.43%
97,162 $8.6 Million
Q3 2019

Nov 15, 2019

SELL
$62.98 - $75.72 $59,956 - $72,085
-952 Reduced 0.95%
99,578 $7.54 Million
Q2 2019

Jul 26, 2019

BUY
$65.7 - $83.98 $355,437 - $454,331
5,410 Added 5.69%
100,530 $7.31 Million
Q1 2019

May 09, 2019

BUY
$77.14 - $90.79 $448,646 - $528,034
5,816 Added 6.51%
95,120 $7.67 Million
Q4 2018

Feb 04, 2019

BUY
$77.85 - $96.01 $351,959 - $434,061
4,521 Added 5.33%
89,304 $8.23 Million
Q3 2018

Nov 05, 2018

BUY
$88.91 - $98.84 $2.73 Million - $3.04 Million
30,728 Added 56.85%
84,783 $8.02 Million
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $2.02 Million - $2.39 Million
-22,529 Reduced 29.42%
54,055 $5.01 Million
Q1 2018

Apr 25, 2018

SELL
$92.01 - $123.21 $405,856 - $543,479
-4,411 Reduced 5.45%
76,584 $7.25 Million
Q4 2017

Feb 06, 2018

SELL
$89.56 - $98.21 $334,327 - $366,617
-3,733 Reduced 4.41%
80,995 $7.83 Million
Q3 2017

Nov 08, 2017

BUY
$69.85 - $89.22 $5.92 Million - $7.56 Million
84,728
84,728 $7.53 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $354B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Regal Investment Advisors LLC Portfolio

Follow Regal Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regal Investment Advisors LLC with notifications on news.